THOMAS GIORDANO to Thyroid Neoplasms
This is a "connection" page, showing publications THOMAS GIORDANO has written about Thyroid Neoplasms.
Connection Strength
1.669
-
Update on Somatic Genomic Alterations in Follicular Cell-Derived Thyroid Cancers. Endocrinol Metab Clin North Am. 2025 Sep; 54(3):497-519.
Score: 0.747
-
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007 May 09; 297(18):2010-7.
Score: 0.215
-
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 2021 03; 31(3):337-386.
Score: 0.140
-
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Mod Pathol. 2020 07; 33(7):1264-1274.
Score: 0.130
-
Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features. JAMA Oncol. 2018 08 01; 4(8):1125-1126.
Score: 0.117
-
Genetic variants in thyroid cancer distant metastases. Endocr Relat Cancer. 2016 10; 23(10):L33-6.
Score: 0.102
-
Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma. Thyroid. 2016 Apr; 26(4):512-7.
Score: 0.100
-
A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. Thyroid. 2010 Sep; 20(9):975-80.
Score: 0.068
-
Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol. 2006 Feb; 30(2):216-22.
Score: 0.049